HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R X Zhang Selected Research

Neuroprotective Agents

12/2012Neuroprotective effect of neurotropin on chronic oxaliplatin-induced neurotoxicity in stage II and stage III colorectal cancer patients: results from a prospective, randomised, single-centre, pilot clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R X Zhang Research Topics

Disease

6Allergic Rhinitis
04/2022 - 01/2007
4Inflammation (Inflammations)
07/2019 - 10/2005
3Neoplasms (Cancer)
12/2018 - 04/2017
3Colorectal Neoplasms (Colorectal Cancer)
04/2017 - 05/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2017 - 10/2014
2Pain (Aches)
08/2012 - 10/2005
1Lymphatic Metastasis
02/2022
1Gaucher Disease (Gaucher's Disease)
04/2020
1Bone Diseases (Bone Disease)
04/2020
1Sneezing
04/2019
1Pituitary Neoplasms (Pituitary Adenoma)
12/2018
1Optic Nerve Diseases (Optic Neuropathy)
12/2018
1Cerebrospinal Fluid Leak
12/2018
1Hyperplasia
11/2018
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
04/2017
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
04/2017
1Ischemia
04/2015
1Hypoxia (Hypoxemia)
04/2015
1Necrosis
04/2015
1Hyperalgesia
08/2012
1Hand-Foot Syndrome
05/2012
1Lymphadenitis (Adenitis)
12/2008
1Respiratory Tract Diseases (Respiratory Tract Disease)
12/2008
1Sarcoidosis (Schaumann Disease)
12/2008
1Tuberculosis (Tuberculoses)
12/2008
1Emphysema
12/2008
1Blister (Bulla)
12/2008
1Hypersensitivity (Allergy)
01/2007
1Rhinitis
01/2007
1Edema (Dropsy)
10/2005
1Hyperglycemia
07/2004
1Infections
01/2000

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
07/2019 - 10/2005
2Small Interfering RNA (siRNA)IBA
07/2019 - 04/2019
1OzoneIBA
04/2022
1Beclin-1IBA
07/2019
1Interleukin-6 (Interleukin 6)IBA
07/2019
1Immunoglobulin E (IgE)IBA
04/2019
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
04/2019
1OvalbuminIBA
11/2018
1Substance PIBA
10/2018
1Proteins (Proteins, Gene)FDA Link
04/2017
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2015
1ErbB Receptors (EGF Receptor)IBA
10/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2014
1Gefitinib (Iressa)FDA Link
10/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2012
1Neuroprotective AgentsIBA
12/2012
1neurotropinIBA
12/2012
1Freund's AdjuvantIBA
08/2012
1Adrenergic Receptors (Adrenergic Receptor)IBA
08/2012
1Serotonin (5 Hydroxytryptamine)IBA
08/2012
1Serotonin ReceptorsIBA
08/2012
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2012
1Capecitabine (Xeloda)FDA Link
05/2012
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2012
1Celecoxib (Celebrex)FDA Link
05/2012
1Formaldehyde (Formol)FDA Link
12/2008
1ParaffinIBA
12/2008
1DNA (Deoxyribonucleic Acid)IBA
12/2008
1Complementary DNA (cDNA)IBA
01/2007
1ChemokinesIBA
01/2007
13'-deoxy-5-(cyanine dye 3)uridine 5'-trisphosphateIBA
01/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2005
1Interleukin-1beta (Interleukin 1 beta)IBA
10/2005
1FrankincenseIBA
10/2005
1Glucose (Dextrose)FDA LinkGeneric
07/2004
1Epinephrine (Adrenaline)FDA LinkGeneric
07/2004
1Albendazole (Albenza)FDA Link
01/2000

Therapy/Procedure

3Drug Therapy (Chemotherapy)
08/2017 - 05/2012
2Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2017 - 10/2005
1Radiotherapy
02/2022
1Esophagectomy
02/2022
1Splenectomy
04/2020
1Enzyme Replacement Therapy
04/2020
1Decompression
12/2018
1Therapeutics
08/2017
1Neoadjuvant Therapy
04/2017
1Electroacupuncture
08/2012
1Immunotherapy
01/2007